Nykode Therapeutics AS (OSL:NYKD)
Norway · Delayed Price · Currency is NOK 2.970
-0.170 (-5.41%)
At close: Mar 13, 2026
Nykode Therapeutics AS Revenue
In the year 2025, Nykode Therapeutics AS had annual revenue of $453.00K USD, down -95.05%.
Revenue
$453.00K
Revenue Growth
-95.05%
P/S Ratio
212.38
Revenue / Employee
$7.68K
Employees
59
Market Cap
969.84M NOK
Revenue Chart
* This company reports financials in USD.
Revenue History
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 453.00K | -8.71M | -95.05% |
| Dec 31, 2024 | 9.16M | -4.17M | -31.26% |
| Dec 31, 2023 | 13.32M | 4.29M | 47.56% |
| Dec 31, 2022 | 9.03M | -26.74M | -74.76% |
| Dec 31, 2021 | 35.77M | -179.93M | -83.42% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2017 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
| Dec 31, 2016 | Upgrade Pro | Upgrade Pro | Upgrade Pro |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| ArcticZymes Technologies ASA | 118.21M |
| Aqua Bio Technology ASA | 101.51M |
| Arctic Bioscience AS | 45.90M |
| SoftOx Solutions AS | 13.59M |
| PCI Biotech Holding ASA | 4.69M |
| Lytix Biopharma AS | 377.00K |
| Circio Holding ASA | 123.00K |
| Zelluna ASA | 53.00K |
Nykode Therapeutics AS News
- 17 days ago - Q4 2025 Nykode Therapeutics ASA Earnings Call Transcript - GuruFocus